This COVID-19 Detector Has Berkeley Lab Roots

How an atomically thin device could become a biotech breakthrough
Lawrence Berkeley National Laboratory

Newswise — A technology spun from carbon nanotube sensors discovered 20 years ago by Lawrence Berkeley National Laboratory (Berkeley Lab) scientists could one day help healthcare providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2. 

When Alex Zettl, Marvin Cohen, and their research teams at Berkeley Lab first demonstrated ultrasensitive oxygen sensors devised from carbon nanotubes – hollow carbon wires with walls no thicker than an atom– they envisioned a broad spectrum of applications, such as gas-leak detectors or air- and water-pollution detectors.

Subsequent studies out of Zettl’s lab revealed that carbon nanotubes – or CNTs – could also be used to detect proteins or carbohydrates at the level of single cells for biological and medical applications. “CNTs’ exquisite chemical sensitivity had dramatic life-science implications that could benefit society,” Zettl said.

But since Zettl normally investigates atomically thin materials known as nanomaterials for the Department of Energy’s “Novel sp2-Bonded Materials and Related Nanostructures” program, his lab is set up for launching exciting new experiments in quantum physics, not new applications for entrepreneurial startups.

So in 2000, Zettl and Cohen, who are both senior faculty scientists in Berkeley Lab’s Materials Sciences Division and physics professors at UC Berkeley, branched out into the world of commercial spin-offs by co-founding the Emeryville-based biotech company Nanomix Inc. They currently sit on the company’s board of directors – Zettl participates as an adviser, and Cohen as a member.

Today, the company is one of many U.S. companies vying for FDA Emergency Use Authorization (EUA) to deploy new diagnostic tests for COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2.

Last month, the company was awarded approximately $570,000 in funding from the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) to develop disposable cartridges that test for protein traces of the coronavirus – known as antigens – in nasal swab samples, and for antibodies to the coronavirus in blood samples.

Patient samples loaded onto the cartridges are analyzed by the Nanomix “eLab,” a handheld testing device the company first developed more than five years ago in response to the Ebola virus epidemic.

The cartridges rely on tiny carbon biosensors modeled after the Zettl and Cohen labs’ groundbreaking carbon nanotube technology to detect coronavirus antigens during the early stages of a current infection. In addition, the cartridges can test for antibodies the immune system builds up as part of our body’s natural defense mechanism against a previous SARS-CoV-2 infection. The company says the eLab system can produce test results in about 15 minutes.

If granted FDA Emergency Use Authorization, the company hopes to have COVID-19-ready eLab products available for healthcare providers in June, and to scale up its supply and production capacity to provide hundreds of thousands of test kits, said Nanomix President and CEO David Ludvigson.

“The fact that my research could help so many people is very rewarding. I'm happy that I was able to contribute in that way,” Zettl said.  

###

Founded in 1931 on the belief that the biggest scientific challenges are best addressed by teams, Lawrence Berkeley National Laboratory and its scientists have been recognized with 13 Nobel Prizes. Today, Berkeley Lab researchers develop sustainable energy and environmental solutions, create useful new materials, advance the frontiers of computing, and probe the mysteries of life, matter, and the universe. Scientists from around the world rely on the Lab’s facilities for their own discovery science. Berkeley Lab is a multiprogram national laboratory, managed by the University of California for the U.S. Department of Energy's Office of Science.

 

DOE’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit energy.gov/science.

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 3765
Released: 23-Oct-2020 10:45 AM EDT
New Data on Increasing Cloth Mask Effectiveness
Society for Risk Analysis (SRA)

A new study published in Risk Analysis, “Reinventing cloth masks in the face of pandemics,” by Stephen Salter, P.Eng., describes how Effective Fiber Mask Programs (EFMPs) can help communities find a balance between the economy and curbing community spread.

Newswise: Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Released: 23-Oct-2020 10:40 AM EDT
Research Team Discovers the Molecular Processes in Kidney Cells That Attract and Feed COVID-19
Michigan Medicine - University of Michigan

What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Oct-2020 11:00 AM EDT Released to reporters: 23-Oct-2020 8:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Oct-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Released: 22-Oct-2020 2:40 PM EDT
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
University of Maryland Medical Center

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 22-Oct-2020 2:25 PM EDT
Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
Massachusetts General Hospital

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH).

Released: 22-Oct-2020 2:10 PM EDT
New York Gov. Andrew Cuomo said that nursing homes "never needed" to accept patients who tested positive for COVID-19, but they did accept them
Newswise

According to a report from the New York State Department of Health, "6,326 COVID-positive residents were admitted to [nursing home] facilities" following Cuomo's mandate that nursing homes accept the readmission of COVID-positive patients from hospitals. Therefore we rate his claim as false.

Released: 22-Oct-2020 2:10 PM EDT
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

Newswise: UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
Released: 22-Oct-2020 1:50 PM EDT
UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
University of Nevada, Las Vegas (UNLV)

As the race for a COVID-19 vaccine intensifies, health care officials are reminding the public not to forget another important vaccine this fall: the flu shot. Flu season in the U.S. technically began in September, with illnesses expected to peak in December and February, according to the Centers for Disease Control (CDC). Less than half of Americans received a flu vaccine during the 2019-2020 flu season, and a staggering 405,000 hospitalizations and 22,000 deaths were attributed to influenza.

Newswise: 246630_web.jpg
Released: 22-Oct-2020 1:45 PM EDT
Immune response the probable underlying cause of neural damage in COVID-19
University of Gothenburg

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

Released: 22-Oct-2020 1:35 PM EDT
COVID-19 study: Meaning in life and self-control protect against stress
University of Innsbruck

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.


Showing results

1120 of 3765

close
1.25302